ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Severity-based evaluation of dynamic air…

Severity-based evaluation of dynamic airway collapse and tracheobronchomalacia: integrated clinical, functional and bronchoscopic assessment with a diagnostic–therapeutic algorithm in a prospective cohort

Respiratory Medicine·July 31
Respiratory SystemPractice changingExcessive Dynamic Airway CollapseObstructive Sleep ApneaTracheobronchomalaciaProspective Observational StudyContinuous Positive Airway PressureAdultCPAPCPAP

Summary

View source

What was studied

A prospective observational study of 74 patients undergoing flexible bronchoscopy (Jan 2023–Mar 2025) evaluated clinical, functional, and endoscopic features of dynamic airway collapse (EDAC/tracheobronchomalacia) by severity, and developed a diagnostic-therapeutic algorithm including CPAP.

Key findings

Dynamic airway collapse ≥50% was found in 67.6% of patients; most met the stricter ≥70% threshold for clinically significant disease. Higher collapse severity correlated with higher BMI (r=0.28, p=0.015) and CPAP initiation (r=0.326, p=0.0046). Of CPAP-treated patients, 88.2% reported clinical improvement. Notably, 58.5% of those with significant collapse had normal spirometry, and OSA prevalence was 84%.

Study limitations

Single-center prospective cohort with only 74 patients, limiting generalizability. The proposed diagnostic-therapeutic algorithm has not been externally validated. No significant correlation between AHI and collapse severity limits conclusions about OSA as a driver of disease.

Clinical implications

Normal spirometry does not rule out clinically significant dynamic airway collapse—bronchoscopy is needed for diagnosis. A severity-based threshold (≥70%) rather than the traditional ≥50% cut-off better guides treatment decisions, and CPAP should be considered in eligible patients, with most reporting symptom improvement.

Caveats

  • Level of evidence assigned as 3 (prospective cohort); no control group or randomization was used.
  • Sex distribution of the cohort is not explicitly reported in the abstract; 'mixed' sex tag is assumed based on typical bronchoscopy cohort composition.
  • The CPAP 'brand' tag is flagged as ambiguous — CPAP is a device modality, not a proprietary brand name; included for searchability only.
Show all 4
  • The 'practice_changing' impact flag was applied cautiously — the algorithm is novel and promising but lacks external validation, so clinical uptake should await further confirmation.

Related Questions

Explore related topics

When should I use CPAP versus stenting for tracheobronchomalacia?How does dynamic bronchoscopy compare to CT for diagnosing excessive dynamic airway collapse?What is the clinical significance of a 70% vs 50% airway collapse threshold in tracheobronchomalacia?

Publication Details

Year
2026
Journal
Respiratory Medicine
Sample Size
n=74
Source
View article
Keep scrolling
More content below.
Up Next